Evidence map›Paper›PMID 32954344›Full record

ArticleBrain communications2020

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's disease.

Lisa Vermunt, Ellen Dicks, Guoqiao Wang, Aylin Dincer, Shaney Flores, Sarah J Keefe, Sarah B Berman, David M Cash, Jasmeer P Chhatwal, Carlos Cruchaga and 22 more

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Sub-Networks of the Brain RHuman brain mapping · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 15 institutions in 6 countries.

Lisa VermuntDepartment of Neurology, Amsterdam Neuroscience, Alzheimer Center Amsterdam, Amsterdam, UMC, VU University, Netherlands.ORCID 0000-0001-7420-6384
Ellen DicksDepartment of Neurology, Amsterdam Neuroscience, Alzheimer Center Amsterdam, Amsterdam, UMC, VU University, Netherlands.ORCID 0000-0003-2496-1626
Guoqiao WangDivision of Biostatistics, Washington University in St. Louis, MO, USA.
Aylin DincerMallinckrodt Institute of Radiology, Washington University in St. Louis, MO, USA.
Shaney FloresMallinckrodt Institute of Radiology, Washington University in St. Louis, MO, USA.
Sarah J KeefeMallinckrodt Institute of Radiology, Washington University in St. Louis, MO, USA.
Sarah B BermanDepartment of Neurology, Alzheimer's Disease Research Center, Pittsburgh, PA.
David M CashUCL Queen Square Institute of Neurology, London, UK.
Jasmeer P ChhatwalDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Carlos CruchagaDepartment of Psychiatry, Washington University in St. Louis, MO, USA.
Nick C FoxDementia Research Centre, Department of Neurodegenerative Disease, UK.
Bernardino GhettiDepartment of Pathology and Laboratory Medicine, Indiana University, IN, USA.
Neill R Graff-RadfordMayo Clinic Florida, FL, USA.
Jason HassenstabKnight Alzheimer's Disease Research Center, Washington University in St. Louis, MO, USA.
Celeste M KarchDepartment of Psychiatry, Washington University in St. Louis, MO, USA.
Christoph LaskeGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Johannes LevinLudwig-Maximilians-Universität München, Germany.
Colin L MastersFlorey Institute, Melbourne, Australia.
Eric McDadeKnight Alzheimer's Disease Research Center, Washington University in St. Louis, MO, USA.
Hiroshi MoriDepartment of Clinical Neuroscience, Osaka City University Medical School, Japan.
John C MorrisKnight Alzheimer's Disease Research Center, Washington University in St. Louis, MO, USA.
James M NobleDepartment of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, GH Sergievsky Center, Columbia University Medical Center, NY, USA.
Richard J PerrinKnight Alzheimer's Disease Research Center, Washington University in St. Louis, MO, USA.
Peter R SchofieldNeuroscience Research Australia, Sydney, Australia.
Chengjie XiongDivision of Biostatistics, Washington University in St. Louis, MO, USA.
Philip ScheltensDepartment of Neurology, Amsterdam Neuroscience, Alzheimer Center Amsterdam, Amsterdam, UMC, VU University, Netherlands.
Pieter Jelle VisserDepartment of Neurology, Amsterdam Neuroscience, Alzheimer Center Amsterdam, Amsterdam, UMC, VU University, Netherlands.
Randall J BatemanDepartment of Psychiatry, Washington University in St. Louis, MO, USA.
Tammie L S BenzingerMallinckrodt Institute of Radiology, Washington University in St. Louis, MO, USA.
Betty M TijmsDepartment of Neurology, Amsterdam Neuroscience, Alzheimer Center Amsterdam, Amsterdam, UMC, VU University, Netherlands.ORCID 0000-0002-2612-1797
Brian A GordonMallinckrodt Institute of Radiology, Washington University in St. Louis, MO, USA.ORCID 0000-0003-2109-2955
Dominantly Inherited Alzheimer Network (DIAN)
Washington University in St. Louis · USAmsterdam Neuroscience · NLColumbia University Irving Medical Center · USGerman Center for Neurodegenerative Diseases · DEIndiana University · USLudwig-Maximilians-Universität München · DEOsaka City University · JPUK Dementia Research Institute · GBUniversity of Pittsburgh · USUNSW Sydney · AUNational Hospital for Neurology and Neurosurgery · GBMaastricht University · NLMassachusetts General Hospital · USMayo Clinic in Florida · USThe University of Melbourne · AU

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Imaging CoreU19AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2010 to 2025
$53.9M
Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI James McCallum Noble · 2020 to 2026
$30.1M
Dominantly Inherited Alzheimer NetworkUF1AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2014 to 2017
$21.6M
Imaging CoreU01AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2008 to 2009
$6.1M
NINDS CENTER CORE FOR BRAIN IMAGINGP30NS098577 · NINDS · WASHINGTON UNIVERSITY · PI HERSHEY, TAMARA G, MARCUS, DANIEL SCOTT · 2016 to 2019
$2.4M
HIGH PERFORMANCE BIOMEDICAL IMAGING COMPUTER RESOURCESS10RR022984 · NCRR · WASHINGTON UNIVERSITY · PI PRIOR, FRED WILLIAM · 2009 to 2009
$1.9M
Neuroimaging Markers of Emerging Dysfunction In Preclinical Alzheimer DiseaseK01AG053474 · NIA · WASHINGTON UNIVERSITY · PI GORDON, BRIAN ANDREW · 2017 to 2021
$623k
GPU COMPUTING RESOURCE TO ENABLE INNOVATION IN IMAGING AND NETWORK BIOLOGYS10OD018091 · OD · WASHINGTON UNIVERSITY · PI PAPPU, ROHIT V, PRIOR, FRED WILLIAM · 2014 to 2014
$598k
NCATS NIH HHS UL1 TR001873NCRR NIH HHS S10 RR022984NIA NIH HHS K01 AG053474NIA NIH HHS P30 AG066462NIA NIH HHS U01 AG032438NIA NIH HHS U19 AG032438NIA NIH HHS UF1 AG032438NIH HHS S10 OD018091NINDS NIH HHS P30 NS098577
6 · The paper itself

Abstract

Structural grey matter covariance networks provide an individual quantification of morphological patterns in the brain. The network integrity is disrupted in sporadic Alzheimer's disease, and network properties show associations with the level of amyloid pathology and cognitive decline. Therefore, these network properties might be disease progression markers. However, it remains unclear when and how grey matter network integrity changes with disease progression. We investigated these questions in autosomal dominant Alzheimer's disease mutation carriers, whose conserved age at dementia onset allows individual staging based upon their estimated years to symptom onset. From the Dominantly Inherited Alzheimer Network observational cohort, we selected T

Indexed as

Alzheimer’s diseaseautosomal dominantdisease progressionnetworksubject-level networks

Identifiers

PMID32954344
PMCPMC7475695
OpenAlexW3043692645

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.